Niagen Bioscience (NAGE) Beginning Cash Balance (2012 - 2018)

Niagen Bioscience (NAGE) has reported Beginning Cash Balance for 7 consecutive years, with $45.4 million the latest figure, recorded in Q1 2018.

• In Q1 2018, Beginning Cash Balance rose 2664.25% year-over-year to $45.4 million; the TTM figure through Mar 2018 stood at $47.0 million (up 553.97% YoY), while the FY2013 annual figure was $520000.0, up 23.76% from the prior year.
• Beginning Cash Balance improved to $45.4 million in Q1 2018 per NAGE's latest filing, from $429.0 in the prior quarter.
• Across five years, Beginning Cash Balance topped out at $45.4 million in Q1 2018 and bottomed at $429.0 in Q3 2017.
• Historically, Beginning Cash Balance has averaged $9.8 million across 5 years, with a median of $3.1 million in 2014.
• Annual changes were most pronounced in 2017 — Beginning Cash Balance slumped 70.41% — and 2018, when it jumped 2664.25%.
• Niagen Bioscience's Beginning Cash Balance stood at $2.3 million in 2014, then soared by 75.33% to $4.0 million in 2015, then soared by 39.98% to $5.5 million in 2016, then slumped by 99.99% to $429.0 in 2017, then soared by 10580086.48% to $45.4 million in 2018.
• Business Quant data shows NAGE's Beginning Cash Balance at $45.4 million in Q1 2018, $429.0 in Q3 2017, and $1.6 million in Q2 2017.